Clinical utility of synergy testing for multidrug-resistant Pseudomonas aeruginosa isolated from patients with cystic fibrosis: ‘the motion for’
- 30 September 2007
- journal article
- review article
- Published by Elsevier in Paediatric Respiratory Reviews
- Vol. 8 (3), 249-255
- https://doi.org/10.1016/j.prrv.2007.04.006
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Antimicrobial Susceptibility and Synergy Studies of Burkholderia cepacia Complex Isolated from Patients with Cystic FibrosisAntimicrobial Agents and Chemotherapy, 2007
- Outcomes of Adults with Cystic Fibrosis Infected with Antibiotic-Resistant Pseudomonas aeruginosaRespiration, 2006
- Hypermutation Is a Key Factor in Development of Multiple-Antimicrobial Resistance inPseudomonas aeruginosaStrains Causing Chronic Lung InfectionsAntimicrobial Agents and Chemotherapy, 2005
- Single versus combination intravenous antibiotic therapy for people with cystic fibrosisPublished by Wiley ,2005
- Multiple Mechanisms of Antimicrobial Resistance in Pseudomonas aeruginosa: Our Worst Nightmare?Clinical Infectious Diseases, 2002
- Identification and Antimicrobial Susceptibility of Alcaligenes xylosoxidans Isolated from Patients with Cystic FibrosisJournal of Clinical Microbiology, 2001
- Antibiotic therapy against Pseudomonas aeruginosa in cystic fibrosis: a European consensusEuropean Respiratory Journal, 2000
- High Frequency of Hypermutable Pseudomonas aeruginosa in Cystic Fibrosis Lung InfectionScience, 2000
- Comparison of a β-lactam alone versus β-lactam and an aminoglycoside for pulmonary exacerbation in cystic fibrosisThe Journal of Pediatrics, 1999
- Antibiotic Susceptibility of Multiply Resistant Pseudomonas aeruginosa Isolatedfrom Patients with Cystic Fibrosis, Including Candidates for TransplantationClinical Infectious Diseases, 1996